How best can underserved stakeholder groups (e.g., ethnic minorities, socio-economically disadvantaged) and stakeholders from under represented countries (e.g. countries of different income levels) be identified and have meaningful (i.e., purposeful, relevant) involvement in planning and doing rapid reviews, and in sharing the results?
“Please try to involve researchers and clinicians from the developing countries and LMIC. Most of the systematic reviews including the rapid reviews are planned, done, and published in the high-income countries and this evidence has very little relevance to the issues and constraints being faced by patients and clinicians in the LMIC”
“Include patient partners in the early stages, and be creative in finding voices that are not always at the table”
